Into the world—Welcome Bexobrutideg!

Into the world—Welcome Bexobrutideg!

Accelerate the Cure Into the world—Welcome Bexobrutideg! We recently wrote about a new type of drug—a BTK degrader— that emerged in 2024, for phase one trials at Nurix Therapeutics and BeOne. The Nurix trial earned FDA fast-track status in December. In a short three...
IWMF Commits To Largest Research Package Since Inception!

IWMF Commits To Largest Research Package Since Inception!

IWMF Commits to Largest Research Package Since Inception! From IWMF Torch, October 2024 IWMF is making outstanding progress in the search for a cure. “Once we do a better job at shutting down the signaling of that mutated MYD88 gene, we will find that cure,” says Dr....
IWMF ANNOUNCES 2024 RESEARCH GRANT RECIPIENTS

IWMF ANNOUNCES 2024 RESEARCH GRANT RECIPIENTS

IWMF has committed to the biggest package of research since its inception. Our vision—A world without WM—is finally within reach as summarized by Dr. Steven Treon, of Dana-Farber Cancer Institute, “Once we do a better job at shutting down the signaling of that...
IWMF Issues New Request for Proposals  to Global WM Researchers

IWMF Issues New Request for Proposals to Global WM Researchers

On July 17th,The latest Request for Proposals (RFP) was sent to nearly 300 WM researchers around the world. The RFP is a result of the ongoing collaborative endeavor between the IWMF and LLS that began in 2015 with the development of the IWMF-LLS Strategic Research...